Table 5.
r-hIFN β-1a (n = 24, %) | r-hIFN β-1a + ribavirin (n = 35, %) | |
Fatigue | 4 (16.7) | 4 (11.4) |
Pyrexia | 2 (8.3) | 6 (17.1) |
Anemia | 0 (0.0) | 6 (17.1) |
Erythema | 4 (16.7) | 2 (5.7) |
Headache | 4 (16.7) | 0 (0.0) |
Thrombocytopenia | 3 (12.5) | 0 (0.0) |
Neutropenia | 0 (0.0) | 2 (5.7) |
Depression | 2 (8.3) | 0 (0.0) |
Insomnia | 0 (0.0) | 2 (5.7) |
Weight loss | 0 (0.0) | 2 (5.7) |